Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 21:33 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
NCT02558023 · University Hospital, Strasbourg, France · PHASE3 · terminated · last registry update 2020-08-25 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “no candidats” | – | Registry record, University Hospital, Strasbourg, France |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CACNA1C within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-06-16Results posted on the registry: University of Birmingham, Bisoprolol + Digoxin (NCT02391337)
- 2021-05-14Phase 3 first posted: University of Calgary, 2% Diltiazem ointment with 1.5% lidocaine + 0.3% Nifedipine ointment with 1.5% lidocaine (NCT04887818)
- 2021-04-27Results posted on the registry: Theracos, Bexagliflozin + Probenecid (NCT03296800)
- 2021-03-23Results posted on the registry: Gillette Children's Specialty Healthcare, Verapamil (NCT01607073)
- 2021-03-22Also stopped (terminated): Cambridge University Hospitals NHS Foundation Trust, Albuterol Sulfate + Nicardipine Hydrochloride (NCT03098680)
- 2021-03-11Also stopped (withdrawn): University Hospital, Lille, Hydroxychloroquine + Association of diltiazem and niclosamide (NCT04372082)
- 2021-03-02Phase 3 first posted: Radboud University Medical Center, Diltiazem Hydrochloride + Placebo (NCT04777045)
- 2021-02-05Phase 3 first posted: Affiliated Hospital of North Sichuan Medical College, Levamlodipine + Amlodipine (NCT04740840)
- 2021-02-03Also stopped (terminated): Arthrex, Inc., a drug against CACNA1C (NCT01790113)
- 2021-01-29Results posted on the registry: Arthrex, Inc., a drug against CACNA1C (NCT01790113)
- 2020-11-06Results posted on the registry: Gilead Sciences, Ranolazine + Dronedarone (NCT01522651)
- 2020-09-04Phase 3 first posted: Pr. Semir Nouira, Nicardipine (NCT04538534)
- 2020-07-17Results posted on the registry: Stefan Soderberg, Leptin infusion plus vasodilators in healthy men + Leptin infusion in healthy men (NCT04374500)
- 2020-06-30Also stopped (suspended): National University of Ireland, Galway, Ireland, Thiazide or Thiazide-like diuretics + Calcium Channel Blockers (NCT04330300)
- 2020-06-26Results posted on the registry: Eli Lilly and Company, LY2623091 + Itraconazole (NCT02300259)
- 2020-05-01Phase 3 first posted: University Hospital, Lille, Hydroxychloroquine + Association of diltiazem and niclosamide (NCT04372082)
- 2020-04-17Phase 3 first posted: Nicolaus Copernicus University, Amiodarone + Verapamil (NCT04351763)
- 2020-02-19Phase 3 first posted: University of Auckland, New Zealand, Metronidazole cream + Metronidazole and Diltiazem cream (NCT04276298)
- 2020-01-18Phase 3 first posted: Jaeb Center for Health Research, verapamil 120mg tablet + placebo (NCT04233034)
- 2020-01-18Results posted on the registry: Food and Drug Administration (FDA), Ranolazine + Verapamil (NCT03070470)
- 2020-01-18Results posted on the registry: University of California, San Diego, Ranolazine + Placebo (NCT01505179)
- 2020-01-14Also stopped (terminated): Bispebjerg Hospital, Diltiazem (NCT02158013)
- 2019-09-18Also stopped (withdrawn): Johns Hopkins University, Nimodipine + Verapamil ER (NCT03150524)
- 2019-08-26Results posted on the registry: Mayo Clinic, Rate or Rhythm Control Therapy (NCT00911508)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision